Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Poseida Therapeutics
Biotech
Tariffs make M&A decisions 'more difficult,' says Roche CEO
Big Pharma M&A will likely take a hit if the U.S. government lives up to its threats of imposing tariffs on the industry, Roche’s CEO has warned.
James Waldron
Apr 24, 2025 4:40am
A look at how Roche's $1.5B Poseida buyout came together
Dec 10, 2024 12:30pm
Roche inks $1.5B Poseida buyout to land off-the-shelf CAR-Ts
Nov 26, 2024 6:00am
Poseida gene therapy reduces kallikrein protein levels in mice
Oct 24, 2024 1:20pm
Astellas hops into Poseida's car for $50M cell therapy collab
May 1, 2024 12:49pm
Poseida examines CAR-T conditioning to crack into solid tumors
Apr 10, 2024 10:32am
